Approval · Notice of Compliance 11366 · 2010
PMS-FINASTERIDE: Notice of Compliance 11366
Issued May 12, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11366
- Date
- May 12, 2010
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Type II 5 alpha-reductase inhibitor
- Canadian reference product
- PROPECIA (Merck Frosst Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-FINASTERIDE | 02320169 | Marketed |
Medicinal ingredients
- FINASTERIDE 1 MG per TAB